ScholarIQanswers from OpenAlex

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker

PaperCitations, authors & open-access status

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker have?

ScholarIQcitation count

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker has 1 citations in the OpenAlex counts ScholarIQ stores.

When was Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker published?

ScholarIQyear

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker has 2012 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker?

ScholarIQoa status

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker has hybrid oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker?

ScholarIQdoi

The DOI for Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker is on the source record.

Open the DOI →

What is the OpenAlex record for Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker?

ScholarIQopenalex

The OpenAlex for Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker is on the source record.

Open the OpenAlex →